218 Autologous glioblastoma tumor cells and an antisense oligonucleotide against insulin-like growth factor type 1 receptor protect against tumor challenge and generate T cell anti-tumor responses

• David Andrews,
• Mark Exley,
• Charles Scott,
• Jenny Zilberberg,
• Amelia Zellander,
• Kenneth Kirby,
• Christopher Uhl,
• Christopher Cultrara

Affiliations

David Andrews

7 Princess Margaret Hospital, Perth, Western Australia, Australia

Mark Exley

Agenus, Lexington, MA, USA

Charles Scott

senior director

Jenny Zilberberg

1Imvax, Philadelphia, PA, USA

Amelia Zellander

1Imvax, Philadelphia, PA, USA

Kenneth Kirby

1Imvax, Philadelphia, PA, USA

Christopher Uhl

1Imvax, Philadelphia, PA, USA

Christopher Cultrara

1Imvax, Philadelphia, PA, USA